drugset / Trial / NCT04930796

Food Effect Study of VER-01 in Healthy Volunteers

NCT04930796 ↗

Phase 1 Completed 18 enrolled Vertanical GmbH
RandomizedCrossoverOpen-labelTreatment

Summary

Evaluation of pharmacokinetics, tolerability and safety of VER-01 depending on the intake a high-fat meal in healthy volunteers

Timeline

Start
2022-08-10
Primary completion
2022-11-17
Completion
2022-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject VER-01 Unknown 10 mg Oral

Indications

No indication recorded.